Clinical Trials & Tribulations: Tales of 21st Century Drug Development

• Navigating Clinical Trial Challenges – Insights on patient recruitment, regulatory hurdles, funding constraints, and managing trial complexity.
• Innovations and Emerging Trends – The role of technology, decentralized trials, patient-centric approaches, and the future of clinical research.
• Ethical and Strategic Considerations – Diversity in trials, handling adverse events, sponsor-CRO collaboration, and lessons learned from real-world experiences.

Speakers

Robin Hume – Moderator
Head of Regulatory Affairs and Quality Assurance, Lava Therapeutics

Kimberley Buytaert-Hoefen, Ph.D
COO, Versiti Clinical Trial Services, Pearl Pathways

Dr. Amy R. Lankford
SVP, Head of Clinical Operations and Regulatory Affairs, Precigen

Bryan Manning
Founder and CEO, Clinical Enrollment

Joel Selzer
CEO, ArcheMedX